Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2017

Study Completion Date

January 31, 2018

Conditions
Pantothenate Kinase-associated Neurodegeneration (PKAN)
Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

collaborator

Oregon Clinical and Translational Research Institute

OTHER

lead

Susan J. Hayflick

OTHER